Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 1.354
Titolo Tipologia Data di pubblicazione Autori File
Rationale of the Inclusion of β-Blockers Among Major Antihypertensive Drugs in the 2023 European Society of Hypertension Guidelines 01 - Articolo su rivista 2024 Mancia, GiuseppeGrassi, Guido +
Orthostatic hypotension an important phenotype in the 2023 European Society of Hypertension guidelines: how to measure it? 01 - Articolo su rivista 2024 Mancia G. +
The 2023 European Society of Hypertension guidelines for high blood pressure – What's new on diagnostic and therapeutic approaches 01 - Articolo su rivista 2024 Grassi G.Mancia G. +
Cardio-Ankle Vascular Index As A Marker Of Left Ventricular Hypertrophy In Treated Hypertensives: Findings From The Pamela Study 01 - Articolo su rivista 2024 Cuspidi, CesareFacchetti, RitaQuarti-Trevano, FoscaDell'Oro, RaffaellaMancia, GiuseppeGrassi, Guido
Rationale of treatment recommendations in the 2023 ESH hypertension guidelines 01 - Articolo su rivista 2024 Mancia, GiuseppeGrassi, Guido +
The current best drug treatment for hypertensive heart failure with preserved ejection fraction 01 - Articolo su rivista 2024 Mancia G. +
Why were the 2023 Guidelines of the European Society of Hypertension not developed as Joint Guidelines together with the European Society of Cardiology? 01 - Articolo su rivista 2024 Grassi, GuidoMancia, Giuseppe +
Comparison between visit-to-visit office and 24-h blood pressure variability in treated hypertensive patients 01 - Articolo su rivista 2024 Mancia, GiuseppeFacchetti, RitaQuarti-Trevano, FoscaDell'Oro, RaffaellaCuspidi, CesareGrassi, Guido
The diagnostic approach and management of hypertension in the emergency department 01 - Articolo su rivista 2024 Mancia G. +
New European Guidelines 2023 for Hypertension: When and Why Should We Think About Sleep Apnea? 01 - Articolo su rivista 2024 Grassi G.Mancia G.
Long-term increase in serum uric acid and its predictors over a 25 year follow-up: Results of the PAMELA study 01 - Articolo su rivista 2024 Maloberti, AlessandroDell'Oro, RaffaellaBombelli, MicheleQuarti-Trevano, FoscaFacchetti, RitaMancia, GiuseppeGrassi, Guido
Randomized Clinical Outcome Trials in Hypertension 01 - Articolo su rivista 2024 Mancia G. +
Risk of Dementia During Antihypertensive Drug Therapy in the Elderly 01 - Articolo su rivista 2024 Rea, FedericoCorrao, GiovanniMancia, Giuseppe
THE IMPACT OF RENAL DENERVATION PROCEDURE ON THE USE OF ANTIHYPERTENSIVE DRUGS. A REAL-LIFE INVESTIGATION FROM ITALY 02 - Intervento a convegno 2023 Rea, FMorabito, GCorrao, GMancia, G +
Changes in blood pressure after catheter-based renal denervation in South Africa 01 - Articolo su rivista 2023 Mancia, G +
REAL-WORLD ANALYSIS OF ADHERENCE, OUTCOMES AND HEALTHCARE COSTS OF THE QUADRUPLE COMBINATION PERINDOPRIL, INDAPAMIDE, AMLODIPINE AND BISOPROLOL IN ITALY 02 - Intervento a convegno 2023 Mancia, G +
Long-Term Safety and Efficacy of Renal Denervation in the Global Symplicity Registry Using the Symplicity Spyral Catheter 02 - Intervento a convegno 2023 Mancia, G +
USE OF INITIAL AND SUBSEQUENT ANTIHYPERTENSIVE COMBINATION TREATMENT IN THE CLINICAL PRACTICE. EVIDENCE FROM A POPULATION-BASED INVESTIGATION IN ITALY 02 - Intervento a convegno 2023 Rea, FCorrao, GMancia, G +
AVERAGE ACHIEVED BP <130/80 MMHG IN HIGH-RISK MIDDLE-AGED AND OLDER HYPERTENSIVE PATIENTS PROVIDES STRONG CARDIOVASCULAR PROTECTION EXCEPT IN LEFT VENTRICULAR HYPERTROPHY 02 - Intervento a convegno 2023 Mancia, G +
VISIT-TO-VISIT 24 HOUR BLOOD PRESSURE VARIABILITY VS OFFICE BLOOD PRESSURE VARIABILITY UNDER ANTIHYPERTENSIVE DRUG TREATMENT 02 - Intervento a convegno 2023 Facchetti, RDell'Oro, RCuspidi, CGrassi, GMancia, G +
Mostrati risultati da 1 a 20 di 1.354
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile